Alexander Pertzev

Title: Innovations of Alexander Pertzev in Targeted Therapeutics

Introduction

Alexander Pertzev is an innovative inventor based in Santa Fe, NM (US). He has made significant contributions to the field of biotechnology, particularly in the development of targeted therapeutics. His work focuses on utilizing extracellular vesicles for the delivery of therapeutic agents, which has the potential to revolutionize treatment methodologies.

Latest Patents

Pertzev holds a patent for "Targeted extracellular vesicles for delivery of therapeutics." This invention is directed towards generating extracellular vesicles (EVs) that comprise a foreign RNA molecule or protein, along with at least one foreign membrane surface exposed ligand that specifically binds to a target receptor displayed on a target cell. The patent also encompasses methods for making and using these generated EVs for targeted gene silencing. Additionally, it includes fusion proteins that consist of an extracellular vesicle anchor protein and a second peptide designed to bind to cell-specific receptors. Pertzev's innovative approach has the potential to enhance the precision of therapeutic delivery.

Career Highlights

Alexander Pertzev is associated with Mercury Bio, Inc., where he continues to advance his research and development efforts. His work at the company emphasizes the importance of targeted delivery systems in improving therapeutic outcomes. Pertzev's dedication to innovation in biotechnology is evident through his focused research and patent achievements.

Collaborations

Pertzev has collaborated with notable colleagues, including Richard Thomas Sayre and Tatiana Vinogradova-Shah. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in the field of targeted therapeutics.

Conclusion

Alexander Pertzev's contributions to the field of biotechnology, particularly through his patent on targeted extracellular vesicles, highlight his role as a leading inventor in innovative therapeutic delivery systems. His work promises to pave the way for more effective treatments in the future.